Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Publication of Final Terms

23rd May 2025 17:30

RNS Number : 0577K
Aviva PLC
23 May 2025
 

 

 

 

 

23 May 2025

 

Aviva plc

Publication of Final Terms pursuant to the issue of €600,000,000 Tier 2 Fixed to Floating Rate Notes due August 2056

 

The following Final Terms have been filed with the Financial Conduct Authority (the "FCA") and are available for viewing:

 

Final Terms dated 23 May 2025 (the "Final Terms") relating to the issue by Aviva plc (the "Company") of €600,000,000 Tier 2 Fixed to Floating Rate Notes due August 2056 under the £7,000,000,000 Euro Note Programme (the "Programme") of the Company updated on 17 March 2025. The Programme enables the Company to issue debt instruments, including a range of subordinated securities.

 

The Final Terms should be read in conjunction with the Base Prospectus dated 17 March 2025, as supplemented by a Supplemental Prospectus dated 15 May 2025 (together the "Prospectus").

 

To view the Final Terms, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/0577K_1-2025-5-23.pdf

 

Copies of the following documents are also available from the websites listed below:

 

Prospectus approved by the FCA on 17 March 2025 relating to the Programme

http://www.rns-pdf.londonstockexchange.com/rns/9930A_1-2025-3-17.pdf

 

Supplemental Prospectus approved by the FCA on 15 May 2025 relating to the Programme

http://www.rns-pdf.londonstockexchange.com/rns/9080I_1-2025-5-15.pdf

 

 

The Prospectus and the Supplemental Prospectus have been submitted to the National Storage Mechanism and are available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

-ends-

 

Enquiries:

Media:

Andrew Reid

+44 (0)7800 694 276

Sarah Swailes

+44 (0)7800 694 859

Analysts:

Greg Neilson

+44 (0)7800 694 564

Joel von Sternberg

+44 (0)7384 231 238

Michael O'Hara

+44 (0)7387 234 388

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.

 

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any State or other jurisdiction of the United States, and are subject to Unites States tax law requirements. Subject to certain exceptions, the securities referred to herein may not be offered, sold or delivered in the United States (as defined in Regulation S under the Securities Act) or to, or for the account or benefit of, U.S. persons (as defined in the U.S. Internal Revenue Code of 1986, as amended, and regulations thereunder). The Prospectus may not be accessed from, or transmitted in or into, the United States. Accordingly, these securities may not be offered, sold or delivered in the United States.

 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTQXLFLEELFBBL

Related Shares:

Aviva
FTSE 100 Latest
Value8,726.01
Change-52.04